Why Targeting HDL Should Work as a Therapeutic Tool, but Has Not
Journal of Cardiovascular Pharmacology - United States
doi 10.1097/fjc.0b013e31829d48a5
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)